Why Adapthealth Corp’s (AHCO) Stock Is Up 6.67%

By AAII Staff
March 21, 2023
Featured Tickers:

One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like Adapthealth Corp before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell Adapthealth Corp’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding Adapthealth Corp’s stock price such as:

  • Current stock price and volume
  • Stock price history
  • Upgrades and downgrades from analysts
  • Stock price momentum as measured by its relative strength

About Adapthealth Corp (AHCO)

Before we jump into Adapthealth Corp’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

AdaptHealth Corp. is focused on providing patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is focused on providing sleep therapy equipment, supplies and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps); home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The breadth of the Company’s product is particularly valuable to acute care hospitals, sleep laboratories and long-term care facilities that discharge patients with complex conditions and multiple product needs.

Want to learn more about Adapthealth Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Adapthealth Corp. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

Learn More About A+ Investor

Adapthealth Corp’s Stock Price as of Market Close

As of March 21, 2023, 4:00 PM CST, Adapthealth Corp’s stock price was $14.40.

Adapthealth Corp is up 6.67% from its previous closing price of $13.50.

During the last market session, Adapthealth Corp’s stock traded between $13.41 and $13.70. Currently, there are 134.14 million shares of Adapthealth Corp stock available for purchase.

Adapthealth Corp’s price-earnings (P/E) ratio is currently at 29.4, which is low compared to the Medical Equipment, Supplies & Distribution industry median of 32.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Adapthealth Corp Stock Price History

Adapthealth Corp’s (AHCO) price is currently down 9.94% so far this month.

During the month of March, Adapthealth Corp’s stock price has reached a high of $16.39 and a low of $12.54.

Over the last year, Adapthealth Corp has hit prices as high as $27.48 and as low as $11.40. Year to date, Adapthealth Corp’s stock is down 41.13%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Adapthealth Corp Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 20, 2023, there were 5 analysts who downgraded Adapthealth Corp’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Adapthealth Corp’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

Adapthealth Corp’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Adapthealth Corp (AHCO) by visiting AAII Stock Evaluator.

Relative Price Strength of Adapthealth Corp

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of March 20, 2023, Adapthealth Corp has a weighted four-quarter relative price strength of -7.76%, which translates to a Momentum Score of 35 and is considered to be Weak.

Want to learn more about how Adapthealth Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Adapthealth Corp Stock Price: Bottom Line

As of March 21, 2023, Adapthealth Corp’s stock price is $14.40, which is up 6.67% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell Adapthealth Corp’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.